HEADER RNA 07-MAR-13 4JIY TITLE RNA THREE-WAY JUNCTION STABILIZED BY A SUPRAMOLECULAR DI-IRON(II) TITLE 2 CYLINDER DRUG COMPND MOL_ID: 1; COMPND 2 MOLECULE: 5'-(CGUACG)-3'; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES KEYWDS RNA, THREE-WAY JUNCTION, DRUG-RNA COMPLEX, RNA STRUCTURE RECOGNITION, KEYWDS 2 CYLINDER, SUPRAMOLECULE EXPDTA X-RAY DIFFRACTION AUTHOR R.K.O.SIGEL,J.A.SCHNABL,E.FREISINGER,B.SPINGLER,M.J.HANNON REVDAT 4 28-FEB-24 4JIY 1 REMARK LINK REVDAT 3 06-NOV-13 4JIY 1 JRNL REVDAT 2 02-OCT-13 4JIY 1 JRNL REVDAT 1 04-SEP-13 4JIY 0 JRNL AUTH S.PHONGTONGPASUK,S.PAULUS,J.SCHNABL,R.K.SIGEL,B.SPINGLER, JRNL AUTH 2 M.J.HANNON,E.FREISINGER JRNL TITL BINDING OF A DESIGNED ANTI-CANCER DRUG TO THE CENTRAL CAVITY JRNL TITL 2 OF AN RNA THREE-WAY JUNCTION. JRNL REF ANGEW.CHEM.INT.ED.ENGL. V. 52 11513 2013 JRNL REFN ISSN 1433-7851 JRNL PMID 24039102 JRNL DOI 10.1002/ANIE.201305079 REMARK 2 REMARK 2 RESOLUTION. 1.91 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.91 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 26.41 REMARK 3 DATA CUTOFF (SIGMA(F)) : 4.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 83.7 REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.234 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.282 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 242 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 4814 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : NULL REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.224 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.271 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 211 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 4030 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 0 REMARK 3 NUCLEIC ACID ATOMS : 125 REMARK 3 HETEROGEN ATOMS : 62 REMARK 3 SOLVENT ATOMS : 39 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : NULL REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : NULL REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : NULL REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : NULL REMARK 3 NUMBER OF RESTRAINTS : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 ANGLE DISTANCES (A) : 0.027 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : NULL REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.040 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : NULL REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.008 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.004 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : NULL REMARK 3 SIMILAR ADP COMPONENTS (A**2) : NULL REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : KLOSTERMAN & SINE REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4JIY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-MAR-13. REMARK 100 THE DEPOSITION ID IS D_1000078104. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-DEC-09; 12-SEP-09 REMARK 200 TEMPERATURE (KELVIN) : 100; 100 REMARK 200 PH : 8.5; 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 2 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y; Y REMARK 200 RADIATION SOURCE : SLS; SLS REMARK 200 BEAMLINE : X06DA; X06DA REMARK 200 X-RAY GENERATOR MODEL : NULL; NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M; M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9999; 0.9999 REMARK 200 MONOCHROMATOR : BARTELS MONOCHROMATOR; BARTELS REMARK 200 MONOCHROMATOR REMARK 200 OPTICS : MIRROR, BARTELS MONOCHROMATOR, REMARK 200 DUAL CHANNEL CUT CRYSTALS, REMARK 200 TOROIDAL MIRROR; MIRROR, BARTELS REMARK 200 MONOCHROMATOR, DUAL CHANNEL CUT REMARK 200 CRYSTALS, TOROIDAL MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD; CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD; MARMOSAIC REMARK 200 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS, XPREP REMARK 200 DATA SCALING SOFTWARE : XPREP REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 4030 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.910 REMARK 200 RESOLUTION RANGE LOW (A) : 45.745 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 7.500 REMARK 200 R MERGE (I) : 0.02040 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 27.0600 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.91 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.01 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.7 REMARK 200 DATA REDUNDANCY IN SHELL : 0.99 REMARK 200 R MERGE FOR SHELL (I) : 0.38470 REMARK 200 R SYM FOR SHELL (I) : 0.38470 REMARK 200 FOR SHELL : 2.670 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH; MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELXD REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: THE STRUCTURE FACTOR FILE CONTAINS FRIEDEL PAIRS. REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 70.84 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.22 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG 400, 0.18M MAGNESIUM ACETATE, REMARK 280 0.05M TRIS CHLORIDE, PH 8.5, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293.15K. 15% PEG 400, 0.165M MAGNESIUM ACETATE, REMARK 280 0.05M TRIS CHLORIDE, PH 8.5, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293.15K. 15% PEG 400, 0.165M MAGNESIUM ACETATE, REMARK 280 0.05M TRIS CHLORIDE, PH 8.5, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 3 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 5555 Z,X,Y REMARK 290 6555 Z+1/2,-X+1/2,-Y REMARK 290 7555 -Z+1/2,-X,Y+1/2 REMARK 290 8555 -Z,X+1/2,-Y+1/2 REMARK 290 9555 Y,Z,X REMARK 290 10555 -Y,Z+1/2,-X+1/2 REMARK 290 11555 Y+1/2,-Z+1/2,-X REMARK 290 12555 -Y+1/2,-Z,X+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 22.87250 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 22.87250 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 22.87250 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 22.87250 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 22.87250 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 22.87250 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY2 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY1 6 0.000000 0.000000 1.000000 22.87250 REMARK 290 SMTRY2 6 -1.000000 0.000000 0.000000 22.87250 REMARK 290 SMTRY3 6 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY1 7 0.000000 0.000000 -1.000000 22.87250 REMARK 290 SMTRY2 7 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 1.000000 0.000000 22.87250 REMARK 290 SMTRY1 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY2 8 1.000000 0.000000 0.000000 22.87250 REMARK 290 SMTRY3 8 0.000000 -1.000000 0.000000 22.87250 REMARK 290 SMTRY1 9 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 9 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY3 9 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY1 10 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 10 0.000000 0.000000 1.000000 22.87250 REMARK 290 SMTRY3 10 -1.000000 0.000000 0.000000 22.87250 REMARK 290 SMTRY1 11 0.000000 1.000000 0.000000 22.87250 REMARK 290 SMTRY2 11 0.000000 0.000000 -1.000000 22.87250 REMARK 290 SMTRY3 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY1 12 0.000000 -1.000000 0.000000 22.87250 REMARK 290 SMTRY2 12 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY3 12 1.000000 0.000000 0.000000 22.87250 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE RNA THREE-WAY JUNCTION IS GENERATED FROM THE ASYMMETRIC REMARK 300 UNIT BY THE OPERATIONS. THE TERMINAL 1/3 CYLINDER LIGANDS ARE PART REMARK 300 OF THE INFINITE CRYSTAL LATTICE. REMARK 300 REMARK 300 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 300 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 300 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 300 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 300 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 300 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 300 SOFTWARE USED: PISA REMARK 300 TOTAL BURIED SURFACE AREA: 970 ANGSTROM**2 REMARK 300 SURFACE AREA OF THE COMPLEX: 3870 ANGSTROM**2 REMARK 300 CHANGE IN SOLVENT FREE ENERGY: -5.0 KCAL/MOL REMARK 300 APPLY THE FOLLOWING TO CHAINS: A REMARK 300 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 300 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 300 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 300 BIOMT1 2 0.000000 0.000000 1.000000 0.00000 REMARK 300 BIOMT2 2 1.000000 0.000000 0.000000 0.00000 REMARK 300 BIOMT3 2 0.000000 1.000000 0.000000 0.00000 REMARK 300 BIOMT1 3 0.000000 1.000000 0.000000 0.00000 REMARK 300 BIOMT2 3 0.000000 0.000000 1.000000 0.00000 REMARK 300 BIOMT3 3 1.000000 0.000000 0.000000 0.00000 REMARK 300 REMARK 300 BIOMOLECULE: 2 REMARK 300 AUTHOR DETERMINED BIOLOGICAL UNIT: NONAMERIC REMARK 300 APPLY THE FOLLOWING TO CHAINS: A REMARK 300 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 300 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 300 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 300 BIOMT1 2 -1.000000 0.000000 0.000000 68.61750 REMARK 300 BIOMT2 2 0.000000 -1.000000 0.000000 91.49000 REMARK 300 BIOMT3 2 0.000000 0.000000 1.000000 22.87250 REMARK 300 BIOMT1 3 -1.000000 0.000000 0.000000 91.49000 REMARK 300 BIOMT2 3 0.000000 1.000000 0.000000 -22.87250 REMARK 300 BIOMT3 3 0.000000 0.000000 -1.000000 68.61750 REMARK 300 BIOMT1 4 0.000000 0.000000 1.000000 0.00000 REMARK 300 BIOMT2 4 1.000000 0.000000 0.000000 0.00000 REMARK 300 BIOMT3 4 0.000000 1.000000 0.000000 0.00000 REMARK 300 BIOMT1 5 0.000000 0.000000 1.000000 22.87250 REMARK 300 BIOMT2 5 -1.000000 0.000000 0.000000 68.61750 REMARK 300 BIOMT3 5 0.000000 -1.000000 0.000000 91.49000 REMARK 300 BIOMT1 6 0.000000 0.000000 -1.000000 68.61750 REMARK 300 BIOMT2 6 -1.000000 0.000000 0.000000 91.49000 REMARK 300 BIOMT3 6 0.000000 1.000000 0.000000 -22.87250 REMARK 300 BIOMT1 7 0.000000 1.000000 0.000000 0.00000 REMARK 300 BIOMT2 7 0.000000 0.000000 1.000000 0.00000 REMARK 300 BIOMT3 7 1.000000 0.000000 0.000000 0.00000 REMARK 300 BIOMT1 8 0.000000 -1.000000 0.000000 91.49000 REMARK 300 BIOMT2 8 0.000000 0.000000 1.000000 22.87250 REMARK 300 BIOMT3 8 -1.000000 0.000000 0.000000 68.61750 REMARK 300 BIOMT1 9 0.000000 1.000000 0.000000 -22.87250 REMARK 300 BIOMT2 9 0.000000 0.000000 -1.000000 68.61750 REMARK 300 BIOMT3 9 -1.000000 0.000000 0.000000 91.49000 REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4090 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 3040 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -67.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT2 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT1 3 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT3 3 1.000000 0.000000 0.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 FE FE2 A 102 LIES ON A SPECIAL POSITION. REMARK 375 FE FE2 A 103 LIES ON A SPECIAL POSITION. REMARK 375 FE FE2 A 105 LIES ON A SPECIAL POSITION. REMARK 375 FE FE2 A 106 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 207 LIES ON A SPECIAL POSITION. REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 FE2 A 102 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 NPM A 101 N12 REMARK 620 2 NPM A 101 N11 79.1 REMARK 620 N 1 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 FE2 A 103 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 NPM A 101 N14 REMARK 620 2 NPM A 101 N13 80.4 REMARK 620 N 1 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 FE2 A 105 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 NPM A 104 N11 REMARK 620 2 NPM A 104 N12 79.2 REMARK 620 N 1 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 FE2 A 106 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 NPM A 104 N14 REMARK 620 2 NPM A 104 N13 81.0 REMARK 620 N 1 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NPM A 101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FE2 A 102 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FE2 A 103 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NPM A 104 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FE2 A 105 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FE2 A 106 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2ET0 RELATED DB: PDB REMARK 900 THE STRUCTURE OF A THREE-WAY DNA JUNCTION IN COMPLEX WITH A METALLO- REMARK 900 SUPRAMOLECULAR HELICATE REVEALS A NEW TARGET FOR DRUGS REMARK 900 RELATED ID: 3FX8 RELATED DB: PDB REMARK 900 DISTINCT RECOGNITION OF THREE-WAY DNA JUNCTIONS BY A THIOESTER REMARK 900 VARIANT OF A METALLO-SUPRAMOLECULAR CYLINDER ('HELICATE') REMARK 900 RELATED ID: 3I1D RELATED DB: PDB REMARK 900 DISTINCT RECOGNITION OF THREE-WAY DNA JUNCTIONS BY THE TWO REMARK 900 ENANTIOMERS OF A METALLO-SUPRAMOLECULAR CYLINDER ('HELICATE') DBREF 4JIY A 1 6 PDB 4JIY 4JIY 1 6 SEQRES 1 A 6 C G U A C G HET NPM A 101 29 HET FE2 A 102 1 HET FE2 A 103 1 HET NPM A 104 29 HET FE2 A 105 1 HET FE2 A 106 1 HETNAM NPM N-[(1E)-PYRIDIN-2-YLMETHYLENE]-N-[4-(4-{[(1E)-PYRIDIN- HETNAM 2 NPM 2-YLMETHYLENE]AMINO}BENZYL)PHENYL]AMINE HETNAM FE2 FE (II) ION HETSYN NPM 1,1-BIS(N-(4-PHENYL)-2-PYRIDYLCARBOXALDIMINE)METHANE FORMUL 2 NPM 2(C25 H20 N4) FORMUL 3 FE2 4(FE 2+) FORMUL 8 HOH *39(H2 O) LINK N12 NPM A 101 FE FE2 A 102 1555 1555 1.98 LINK N11 NPM A 101 FE FE2 A 102 1555 1555 1.99 LINK N14 NPM A 101 FE FE2 A 103 1555 1555 1.98 LINK N13 NPM A 101 FE FE2 A 103 1555 1555 1.98 LINK N11 NPM A 104 FE FE2 A 105 1555 1555 1.98 LINK N12 NPM A 104 FE FE2 A 105 1555 1555 1.99 LINK N14 NPM A 104 FE FE2 A 106 1555 1555 1.97 LINK N13 NPM A 104 FE FE2 A 106 1555 1555 1.98 SITE 1 AC1 4 C A 1 G A 6 FE2 A 102 FE2 A 103 SITE 1 AC2 1 NPM A 101 SITE 1 AC3 1 NPM A 101 SITE 1 AC4 4 U A 3 A A 4 FE2 A 105 FE2 A 106 SITE 1 AC5 1 NPM A 104 SITE 1 AC6 1 NPM A 104 CRYST1 45.745 45.745 45.745 90.00 90.00 90.00 P 21 3 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021860 0.000000 0.000000 0.00000 SCALE2 0.000000 0.021860 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021860 0.00000